Lilly Expands Oncology Footprint With FDA Win for Pancreatic Cancer Drug

Eli Lilly's experimental cancer treatment, olomorasib, receives orphan drug designation from the Food and Drug Administration.

本文内容来自外部来源，点击「继续访问」将跳转到原始发布站点。